| Record ID | marc_records_scriblio_net/part20.dat:129945317:1126 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part20.dat:129945317:1126?format=raw |
LEADER: 01126pam 2200289 a 4500
001 89001909
003 DLC
005 19900124123015.9
008 890208s1989 onca b 10000 eng c
010 $a 89001909
020 $a0920887465
040 $aDNLM/DLC$cDLC$dDLC
050 10 $aRM405$b.P47 1989
060 $aWE 544 P429 1987
082 00 $a616.7/23061$219
245 00 $aPercutaneous antirheumatic therapy :$ba reappraisal /$cKay Brune, editor.
260 0 $aToronto ;$aLewiston, N.Y. :$bHuber,$cc1989.
300 $a51 p. :$bill. ;$c25 cm.
500 $aBased on a symposium held during the 11th European Congress of Rheumatology held in Athens, Greece, June 28-July 4, 1987.
504 $aIncludes bibliographies.
650 0 $aAntirheumatic agents$xAdministration$xCongresses.
650 0 $aTransdermal medication$xCongresses.
650 2 $aAdministration, Cutaneous$xcongresses.
650 2 $aAnti-Inflammatory Agents, Topical$xtherapeutic use$xcongresses.
650 2 $aRheumatism$xdrug therapy$xcongresses.
700 10 $aBrune, Kay.
711 20 $aEuropean Congress of Rheumatology$n(11th :$d1987 :$cAthens, Greece)